Destination
Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

SLNO shares surge as Neurocrine inks $2.9B cash deal to acquire it at $53 a share, adding Vykat XR and expanding its rare disease and endocrinology portfolio. [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb
Galbot Robots complete 100 consecutive rallies against a tennis champion

Galbot says its robot completed more than 100 consecutive autonomous tennis rallies against former world number 15 Zheng Jie at the World Humanoid Robot Games in Beijing. The rally count, the autonomy [...]

Match Score: 51.16

Destination
Xi Jinping rallies China to close the AI gap with a focus on homegrown chips and software

China's President Xi Jinping called for greater self-reliance in AI development at a Politburo meeting on Friday.<br /> The article Xi Jinping rallies China to close the AI gap with a focus [...]

Match Score: 40.93

Destination
OpenAI rallies 100+ companies to sign open letter warning AI-powered cyberattacks on critical infrastructure are imminent

OpenAI, together with more than 100 companies including Microsoft, Google, Anthropic, Deutsche Telekom, and SAP, has published an open letter on AI-powered cyber defense. The coalition warns of increa [...]

Match Score: 40.93

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 40.15

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 32.12

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 32.12

Destination
Galbot Robots Complete 100 Consecutive Autonomous Tennis Rallies

Humanoid robots built by Beijing-based Galbot played a live autonomous tennis match against human athletes on August 23, 2026, completing more than 100 consecutive rallies in what the company describe [...]

Match Score: 30.70

qz
What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?

Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out. [...]

Match Score: 28.32

qz
Here's Why Relmada Therapeutics (RLMD) Is a Great 'Buy the Bottom' Stock Now

Relmada Therapeutics (RLMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this t [...]

Match Score: 27.94